glp-1 als Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders Beyond Weight Loss: How GLP-1

These cases are not just about a prescription

Because Microdose GLP-1 uses a lower dose of semaglutide or tirzepatide, it may be associated with a lower likelihood and severity of side effects compared to standard doses

While GLP-1 degradation is unaffected by kidney function, the clearance of both GLP-1, and to a greater extent its inactive metabolites, is delayed in patients with renal insufficiency [184]

GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways Cancer Network Staff Ariana Pelosci , Tim Cortese Explore 5 essential takeaways for oncology clinicians regarding the use of GLP-1 receptor agonists in breast cancer management

Never miss out on the latest innovative health care content tailored to you